Structures by: Zhou J. Y.
Total: 12
C31H33BrO5
C31H33BrO5
Organic & biomolecular chemistry (2018) 16, 48 9382-9389
a=10.1745(11)Å b=11.3873(13)Å c=12.2870(14)Å
α=85.634(2)° β=82.125(2)° γ=86.327(2)°
[Ru(dmb)~2~(PNOP)][ClO~4~](H~2~O)(0.5C~6~H~6~)
[Ru(dmb)~2~(PNOP)][ClO~4~](H~2~O)(0.5C~6~H~6~)
Journal of the Chemical Society, Dalton Transactions (1999) 21 3711
a=9.0170(5)Å b=11.4957(6)Å c=22.1396(12)Å
α=79.1360(10)° β=82.1010(10)° γ=88.9300(10)°
C29H29N3O7,H2O
C29H29N3O7,H2O
Chem. Commun. (2017)
a=13.172(3)Å b=6.6186(8)Å c=16.673(3)Å
α=90° β=112.481(18)° γ=90°
[Ru(bpy)2OCP](ClO4)2.2H2O where bpy= 2,2'-bipyridine; OCP=2-(2-chlorophenyl)imidazo[4,5-f]1,10-phenanthroline
C39H31Cl3N8O10Ru
Journal of the Chemical Society, Dalton Transactions (1999) 1 19
a=14.283(2)Å b=16.671(2)Å c=17.596(2)Å
α=90.00° β=91.020(10)° γ=90.00°
C8H7FeN6O
C8H7FeN6O
ACS applied materials & interfaces (2019)
a=32.6735(4)Å b=32.6735(4)Å c=32.6735(4)Å
α=90° β=90° γ=90°
C36H30N4O7Zn
C36H30N4O7Zn
Crystal Growth & Design (2015) 15, 8 4087
a=8.3471(17)Å b=20.085(4)Å c=19.236(4)Å
α=90.00° β=91.51(3)° γ=90.00°
C35H30N2O6Zn
C35H30N2O6Zn
Crystal Growth & Design (2015) 15, 8 4087
a=9.1199(18)Å b=11.616(2)Å c=15.685(3)Å
α=96.54(3)° β=100.43(3)° γ=106.40(3)°
C28H22NO6Zn
C28H22NO6Zn
Crystal Growth & Design (2015) 15, 8 4087
a=9.3717(19)Å b=11.209(2)Å c=12.227(2)Å
α=109.67(3)° β=96.74(3)° γ=96.16(3)°
C26H21N4O6Zn
C26H21N4O6Zn
Crystal Growth & Design (2015) 15, 8 4087
a=8.7037(17)Å b=16.355(3)Å c=18.856(5)Å
α=90.00° β=115.71(2)° γ=90.00°
C42H30N4O11Zn
C42H30N4O11Zn
Crystal Growth & Design (2015) 15, 8 4087
a=9.8893(9)Å b=12.2772(11)Å c=15.8563(16)Å
α=75.014(8)° β=76.456(8)° γ=82.337(7)°
C25H23N2O6Zn
C25H23N2O6Zn
Crystal Growth & Design (2015) 15, 8 4087
a=9.8901(8)Å b=11.0011(7)Å c=11.9223(11)Å
α=82.982(6)° β=77.657(7)° γ=65.772(7)°
C80H62N8O12Zn
C80H62N8O12Zn
Crystal Growth & Design (2015) 15, 8 4087
a=9.5318(19)Å b=12.490(3)Å c=14.214(3)Å
α=76.45(3)° β=86.68(3)° γ=83.09(3)°